The Committee for Medicinal Products for Human Use recommends marketing authorization for Pfizer and BioNTech's updated ...

The Committee for Medicinal Products for Human Use recommends marketing approval for Merck's Keytruda for treating two types ...

The European Medicines Agency’s Committee for Medicinal Products for Human Use has recommended approval of Hetronifly ...

EMA’s human medicines committee recommends marketing approval for Pfizer & BioNTech’s Omicron KP.2-adapted Covid-19 vaccine: New York Monday, September 23, 2024, 10:00 Hrs [IS ...

EMA’s human medicines committee recommends approval of Henlius’ Hansizhuang to treat extensive-stage small cell lung cancer: Shanghai, China Monday, September 23, 2024, 16:00 ...

Recommendation based on a phase 3 study showing a significantly greater proportion of children on Dupixent achieved histological remission, compared to placebo, consistent with improvements seen in ...

This latest FDA decision marks the first approval for SNY's Sarclisa as a first-line treatment for multiple myeloma patients.

AstraZeneca updated the market on two ongoing drug trials on Monday, with a key trial in breast cancer failing to improve ...

(Alliance News) - AstraZeneca PLC on Monday said a breast cancer drug failed to significantly extend patients' lives, a second blow this month to hopes for the product. Datopotamab deruxtecan, also ...

In early UK corporate news, Rightmove received another takeover proposal from REA Group, though the Sydney listing bemoaned a lack of engagement. AstraZeneca backed the "clinical value" for its ...

New indication supported by the MANDARA trial which showed nearly 60% of patients achieved remission and 41% of patients fully stopped taking oral corticosteroids AstraZeneca’s Fasenra (benralizumab) ...

Biohaven's drug for a genetic disease that affects the nervous system met the main study goal, sending its shares up more ...